Correlation Between Quoin Pharmaceuticals and Soluna Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Soluna Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Soluna Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Soluna Holdings Preferred, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Soluna Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Soluna Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Soluna Holdings.

Diversification Opportunities for Quoin Pharmaceuticals and Soluna Holdings

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Quoin and Soluna is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Soluna Holdings Preferred in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soluna Holdings Preferred and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Soluna Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soluna Holdings Preferred has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Soluna Holdings go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Soluna Holdings

Given the investment horizon of 90 days Quoin Pharmaceuticals is expected to generate 5.18 times less return on investment than Soluna Holdings. In addition to that, Quoin Pharmaceuticals is 1.32 times more volatile than Soluna Holdings Preferred. It trades about 0.03 of its total potential returns per unit of risk. Soluna Holdings Preferred is currently generating about 0.19 per unit of volatility. If you would invest  585.00  in Soluna Holdings Preferred on September 3, 2024 and sell it today you would earn a total of  689.00  from holding Soluna Holdings Preferred or generate 117.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Quoin Pharmaceuticals Ltd  vs.  Soluna Holdings Preferred

 Performance 
       Timeline  
Quoin Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Soluna Holdings Preferred 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Soluna Holdings Preferred are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent technical indicators, Soluna Holdings reported solid returns over the last few months and may actually be approaching a breakup point.

Quoin Pharmaceuticals and Soluna Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quoin Pharmaceuticals and Soluna Holdings

The main advantage of trading using opposite Quoin Pharmaceuticals and Soluna Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Soluna Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soluna Holdings will offset losses from the drop in Soluna Holdings' long position.
The idea behind Quoin Pharmaceuticals Ltd and Soluna Holdings Preferred pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm